Large language models (LLMs) are often praised for their ability to process vast amounts of data and provide seemingly expert-level answers. However, a new study published in JAMA Network Open highlights significant LLM limitations when these tools are applied to clinical reasoning. While these models can identify diagnoses with high accuracy, they frequently fail to explain the "why" or "how" behind their conclusions, posing a risk to patient safety and laboratory integrity.
For the lab manager, these findings serve as a critical reminder that while generative AI can assist with administrative tasks, it is not yet a reliable substitute for the specialized expertise of laboratory professionals.
Diagnostic accuracy vs. clinical reasoning
The study, led by researchers from several US institutions, evaluated the performance of multiple LLMs on complex clinical cases. The results revealed a startling gap: the models often arrived at the correct diagnosis but failed to select the appropriate clinical reasoning steps to reach it. In many instances, the AI provided the right answer based on a "best guess" or pattern recognition rather than an actual understanding of the underlying pathophysiology or diagnostic logic.
This phenomenon is known as "shortcut learning." LLMs may identify keywords in a clinical scenario that correlate with a specific disease, but they do not weigh evidence in the same way a human clinician or lab professional does. For example, a model might correctly identify a rare blood disorder but fail to explain which specific laboratory markers led to that conclusion or why other possibilities were ruled out.
The risk of "hallucinations" in the lab
One of the most persistent LLM limitations is the tendency to hallucinate—generating confident but entirely false information. In a clinical or research setting, this can be catastrophic. If a lab manager uses a general-purpose AI to interpret complex assay results or troubleshoot a sensitive instrument protocol, the model might provide a plausible-sounding but technically incorrect solution.
Unlike humans, who can admit when they are uncertain, LLMs are designed to provide an answer regardless of its accuracy. This lack of a "doubt mechanism" means that without rigorous human oversight, AI-generated errors could easily be integrated into laboratory workflows.
Why lab managers must remain the "human in the loop"
The study authors emphasize that AI should be viewed as a tool to augment, not replace, human judgment. In a laboratory context, this means maintaining a "human-in-the-loop" approach. Lab managers must ensure that any AI-generated output is validated by a subject matter expert before it influences clinical decisions or operational protocols.
Strategic implementation of these tools requires a clear understanding of when and when not to use AI chatbots in the lab. While AI can excel at summarizing meetings or drafting basic emails, it lacks the nuanced reasoning required for high-stakes diagnostic interpretation.
Implementing LLMs with rigorous oversight and governance
To mitigate the risks associated with LLM limitations, laboratories need robust governance frameworks. This includes specialized training for staff to recognize the pitfalls of generative AI and to establish clear protocols for AI use. As noted in recent industry findings, trust and training shape the next phase of AI adoption in research and clinical environments.
Lab managers should prioritize tools that offer transparent sourcing and explainable logic. Moving forward, the goal is to maximize AI investments by focusing on narrow, well-defined tasks where the AI’s performance can be easily measured and verified. By treating AI as a sophisticated assistant rather than an autonomous expert, lab leaders can harness the benefits of automation while safeguarding the accuracy of their results.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.








